This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Hokkaido University, Kyoto University. Active years: 2026.
Company Filing History:
1 out of 442 
1 out of 863 
Years Active: 2026
Title: Fumihiko Hattanda: Innovator in Renal Cystic Ciliopathy Treatment
Introduction
Fumihiko Hattanda is a notable inventor based in Sapporo-shi, Hokkaido, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of renal cystic ciliopathy. His innovative work has led to the development of a unique pharmaceutical composition that addresses this medical condition.
Latest Patents
Hattanda holds a patent for a pharmaceutical composition specifically designed for treating and/or preventing renal cystic ciliopathy. This patent represents a crucial advancement in medical science, providing new hope for patients suffering from this condition. He has 1 patent to his name, showcasing his dedication to innovation in healthcare.
Career Highlights
Throughout his career, Hattanda has been associated with prestigious institutions such as Kyoto University and Hokkaido University. His work at these universities has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in the field of medicine.
Collaborations
Hattanda has worked alongside esteemed colleagues, including Kenji Osafune and Shinichi Mae. Their collaborative efforts have further enhanced the impact of his research and innovations in the pharmaceutical industry.
Conclusion
Fumihiko Hattanda's contributions to the treatment of renal cystic ciliopathy highlight his role as an influential inventor in the pharmaceutical field. His dedication to innovation continues to inspire advancements in medical science.